Korea wins U.S. patent for recombinant anthrax vaccine

Published: 2013-08-08 06:57:00
Updated: 2013-08-08 06:57:00
The country's public health and safety agency had won an U.S. patent for the process of manufacturing a recombinant anthrax vaccine, the Korea Centers for Disease Control and Prevention (KCDC) said Tuesday.

The patent, was jointly filed to the U.S. Patent Office by the KCDC and Green Cross Cor...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.